# Biomolecular Life Holdings, Inc. (BIOM)

> Source: Nexqual · https://nexqual.com/BIOM · data as of 2026-10-22 13:30 UTC · cite as "Nexqual, Biomolecular Life Holdings, Inc. (BIOM), nexqual.com/BIOM" · informational, not investment advice.

**Price:** USD 0.91 (+12.35% on the day) · last close of Oct 22, 2026; US market closed, not a live price. Prev close 0.81 · day 0.91–0.91 · 52w 0.03–2.25 · market cap $1.1M · OID

## Key facts
- Last four reported quarters (through Sep 30, 2015): revenue $0K, net income -$4.3M (SEC filings).
- Analysts: None.
- Total return with dividends: 1Y -11.0% vs S&P 500 +13.4%; 5Y -98.0% vs S&P 500 +76.9%.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2013 | FY2014 | TTM |
|---|---|---|---|
| Revenue | $0K | $0K | $0K |
| Operating income | -$3.9M | -$4.1M | -$2.7M |
| Net income | -$7.4M | -$6.2M | -$4.3M |
| EPS (diluted) | -$18200.00 | -$4400.00 | — |
| Free cash flow | -$1.0M | -$1.9M | — |
| Cash + short-term investments | $714K | $34K | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Sep 30, 2015)
Earnings yield -406.67%

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -11.0% | -98.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -11.1% | -54.4% |
| Volatility (annualized) | 633.5% | 376.9% |
| Max drawdown | -98.7% (Oct 2025→Jul 2026) | -99.9% (Oct 2021→Jul 2026) |

## Peers (Shell Companies)
KCHV (Kochav Defense Acquisition Corp) USD 10.51 -0.10% · FVAV (Fortress Value Acquisition Corp) USD 10.04 -0.30% · TACH (Titan Acquisition Corp.) USD 10.55 +0.09% · ALUB (Alussa Energy Acquisition Corp.) USD 10.15 +0.20% · OIM (OneIM Acquisition Corp.) USD 10.11 +0.05% · FCRS (FutureCrest Acquisition Corp.) USD 10.21 +0.10%

## More
Full page: https://nexqual.com/BIOM · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in BIOM's own 10-K filed 2015-04-15 (https://www.sec.gov/Archives/edgar/data/1091326/000101968715001463/vgls_10k-123114.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Company | "promissory note and warrant purchase agreement with MDC, pursuant to which MDC provided us $50,000 in cash." |
| Partner | Fund | "19, 2015, we exercised our right to issue a put notice in the amount of $25,000 under our agreement with Dutchess Opportunity Fund" |
| Partner | Ambiopharm | "We do not currently have a contract or an exclusivity agreement with Ambiopharm." |
| Partner | DMBM | "On February 15, 2013, we entered into a debenture purchase agreement with DMBM, Inc. whereby DMBM was obligated" |
| Partner | DW Odell Company | "promissory note and warrant purchase agreement with DW Odell Company, LLC, pursuant to which DW Odell is obligated to provide us" |
| Partner | Dutchess Opportunity Fund II | "September 4, 2014 and February 4, 2015, we entered into an investment agreement with Dutchess Opportunity Fund II L.P. where Dutchess" |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter (ends 2012-06-30) | — | — | — | $0 | — |
| Current fiscal year (ends 2012-12-31) | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |